| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Ciprofloxacin hydrochloride |
Is a |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Ciprofloxacin measurement |
Component |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Ciprofloxacin adverse reaction (disorder) |
Causative agent (attribute) |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Allergy to ciprofloxacin |
Causative agent (attribute) |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Product containing precisely ciprofloxacin 100 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| ciprofloxacine 2 mg/mL, flacon de 200 mL pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Product containing precisely ciprofloxacin 750 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Product containing precisely ciprofloxacin 500 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Product containing precisely ciprofloxacin 250 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| ciprofloxacine 2 mg/mL, flacon de 50 mL pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| ciprofloxacine 2 mg/mL, flacon de 100 mL pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Ciprofloxacin [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Ciprofloxacin 200mg/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Ciprofloxacin 400mg/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Ciprofloxacin 2mg/mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Ciprofloxacin 200mg/bag injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 100 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Ciprofloxacin 400mg/bag injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Ciprofloxacin 1% injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Ciprofloxacin 5g/100mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Ciprofloxacin 200mg/100mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Ciprofloxacin 200mg solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Ciprofloxacin 400mg solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Ciprofloxacin 1200mg solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Ciprofloxacin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Ciprofloxacin-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Ciprofloxacin-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing ciprofloxacin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Ciprofloxacin 10mg/mL (1%) injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Ciprofloxacin 200mg/100mL intravenous injection solution 100mL premixed bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Ciprofloxacin 400mg/vial injection solution 40mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Ciprofloxacin 200mg/vial injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Ciprofloxacin 400mg/200mL intravenous injection solution 200mL premixed bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Ciprofloxacin 10mg/mL (1%) injection solution 40mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Product containing precisely ciprofloxacin 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Product containing ciprofloxacin and dexamethasone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
2 |
| Ciprofloxacin 0.3% + dexamethasone 0.1% sterile otic suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Ciprofloxacin 500mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Ciprofloxacin 1000mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Ciprofloxacin corneal deposits (disorder) |
Causative agent (attribute) |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
2 |
| Product containing ciprofloxacin in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Ciprofloxacin lactate (substance) |
Is a |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Ciprofloxacin 2 mg/mL ear solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Allergy to ciprofloxacin |
Causative agent (attribute) |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing ciprofloxacin and hydrocortisone in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ciprofloxacin 100 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ciprofloxacin 100 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ciprofloxacin 750 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ciprofloxacin 750 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ciprofloxacin 500 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ciprofloxacin 500 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ciprofloxacin 250 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ciprofloxacin 250 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Ciprofloxacin hydrochloride |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Ciprofloxacin lactate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Ciprofloxacin 500mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Ciprofloxacin 1000mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/mL and dexamethasone 1 mg/mL ear suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
|
| Product containing precisely ciprofloxacin 500 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ciprofloxacin 250 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ciprofloxacin 100 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ciprofloxacin 750 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ciprofloxacin (as ciprofloxacin lactate) 200 milligram/100 milliliter conventional release solution for infusion bag |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ciprofloxacin (as ciprofloxacin lactate) 400 milligram/200 milliliter conventional release solution for infusion bag |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ciprofloxacin (as ciprofloxacin lactate) 100 milligram/50 milliliter conventional release solution for infusion bottle |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Ciprofloxacin- and hydrocortisone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing only ciprofloxacin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing only ciprofloxacin and dexamethasone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
2 |
| Product containing only ciprofloxacin and hydrocortisone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Ciprofloxacin and hydrocortisone only product in otic dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Ciprofloxacin only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Ciprofloxacin only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing only ciprofloxacin in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing only ciprofloxacin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ciprofloxacin (as ciprofloxacin lactate) 2 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Ciprofloxacin (as ciprofloxacin hydrochloride) 750 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 250 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Ciprofloxacin (as ciprofloxacin hydrochloride) 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 100 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/g eye ointment |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Ciprofloxacin 2 mg/mL ear solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Ciprofloxacin 2 mg/mL ear solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 100 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ciprofloxacin 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ciprofloxacin 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ciprofloxacin 2 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ciprofloxacin 2 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/mL and dexamethasone 1 mg/mL ear suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
2 |
| Ciprofloxacin and dexamethasone only product in otic dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
2 |
| Ciprofloxacin- and dexamethasone-containing product in otic dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
2 |
| Ciprofloxacin corneal deposits (disorder) |
Causative agent (attribute) |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 2 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 250 milligram and tinidazole 300 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing ciprofloxacin and tinidazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing only ciprofloxacin and tinidazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Ciprofloxacin- and tinidazole-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Ciprofloxacin and tinidazole only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ciprofloxacin (as ciprofloxacin lactate) 2 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ciprofloxacin (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]